Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aadi Bioscience Q3 2024 GAAP EPS $(0.46), Inline, Sales $7.21M Beat $6.60M Estimate

Author: Benzinga Newsdesk | November 06, 2024 08:01am
Aadi Bioscience (NASDAQ:AADI) reported quarterly losses of $(0.46) per share which met the analyst consensus estimate. The company reported quarterly sales of $7.21 million which beat the analyst consensus estimate of $6.60 million by 9.33 percent. This is a 21.03 percent increase over sales of $5.96 million the same period last year.

Posted In: AADI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist